Skip to main content
Erschienen in: Head and Neck Pathology 4/2019

19.03.2019 | Original Paper

Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia

verfasst von: Joon Koh, Zoya B. Kurago

Erschienen in: Head and Neck Pathology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Proliferative verrucous leukoplakia (PVL) is a premalignant condition of the oral mucosa with > 70% chance of progression to squamous cell carcinoma (SCC), while lacking the common risks and behavior seen in non-PVL oral squamous carcinogenesis. PVL follows a multi-stage slow, relentless and usually multifocal expansion of surface epithelial thickening that over time takes on a verrucous architecture, eventually leading to verrucous carcinoma and/or dysplasia followed by “conventional” SCC, a process that takes years and is notoriously difficult to manage. As mucosal surfaces and carcinomas arising at these sites, are colonized by microorganisms, host receptors for microbial products have received attention as potential contributors to carcinogenesis. Studies show that microbial pattern recognition toll-like receptor (TLR)2 in various epithelial cells is upregulated in premalignant lesions and in malignant cells and can activate oncogenic pathways. Because of the highly progressive nature of PVL, we examined TLR2 expression in well-characterized PVL samples by immunohistochemistry. We found that, similar to epithelial dysplasia and SCC, PVL keratinocytes throughout the epithelial thickness showed diffuse TLR2 expression even in early stage lesions prior to onset of dysplasia. In contrast, oral mucosal samples in the absence of hyperorothokeratosis or dysplasia, expressed TLR2 primarily in the basal and parabasal layers. Given the high rates of PVL transformation and the previously established pro-cancer role of high TLR2 expression in malignant oral squamous cells, it is important to determine how its’ expression and functions are regulated in the oral squamous epithelium, and what is the specific TLR2 role in carcinogenesis.
Literatur
1.
Zurück zum Zitat International Agency for Research on Cancer: WHO classification of head and neck tumours, 4th ed. 2017;Lyon: IARC. International Agency for Research on Cancer: WHO classification of head and neck tumours, 4th ed. 2017;Lyon: IARC.
3.
Zurück zum Zitat Neville BWDD, Allen CM, Chi AC Oral and maxillofacial pathology, 4th ed. 2016;Amsterdam: Elsevier. Neville BWDD, Allen CM, Chi AC Oral and maxillofacial pathology, 4th ed. 2016;Amsterdam: Elsevier.
4.
Zurück zum Zitat Hansen LS, Olson JA, Silverman S. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol. 1985;60(3):285–98.CrossRef Hansen LS, Olson JA, Silverman S. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol. 1985;60(3):285–98.CrossRef
19.
Zurück zum Zitat Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, et al. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res. 2002;62(9):2493–7.PubMed Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, et al. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res. 2002;62(9):2493–7.PubMed
24.
Zurück zum Zitat Palani CD, Ramanathapuram L, Lam-Ubol A, Kurago ZB. Toll-like receptor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases (1/2). Oncotarget. 2018;9(6):6814–29.CrossRef Palani CD, Ramanathapuram L, Lam-Ubol A, Kurago ZB. Toll-like receptor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases (1/2). Oncotarget. 2018;9(6):6814–29.CrossRef
Metadaten
Titel
Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia
verfasst von
Joon Koh
Zoya B. Kurago
Publikationsdatum
19.03.2019
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 4/2019
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-019-01028-y

Weitere Artikel der Ausgabe 4/2019

Head and Neck Pathology 4/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie